Awards Information

Reset

The Award database is continually updated throughout the year. As a result, data for the given year is not complete until April of the following year. Annual Reports data is a snapshot of agency reported information for that year and hence might look different from the live data in the Awards Information charts.

Displaying 1 - 10 of 162567 results
  1. Fully-Integrated Pressure and Temperature Sensitive Polymeric Nano-Coatings for Use in Hypersonic Facilities

    SBC: LeaTech, LLC            Topic: AF141-232

    ABSTRACT: As the geometry of test articles becomes more complex the demand for evolving instrumentation to make global, quantitative surface pressure and temperature measurements across a diverse spectrum of test environments continues to increase. Traditionally, pressure sensitive coatings called pressure sensitive paints (PSPs) have been oxygen sensors. The need for a polymeric pressure sensi ...

    SBIR Phase I 2014 Air ForceDepartment of Defense
  2. Hybrid Battery/Supercapacitor Energy Storage Device

    SBC: ADA Technologies, Inc.            Topic: A15A-T010

    ADA Technologies, Inc. (ADA) and Dr. Massoud Pedram at the University of Southern California (USC) have successfully completed a Phase I STTR effort for the development of a lithium ion (Li-ion)/ supercapacitor hybrid electrical energy storage system (HEESS) to afford pulse power characteristics (projected ~10 kW/kg) in a high energy system (100-150 Wh/kg). The system is enabled via a constant cur ...

    STTR Phase II 2016 Department of DefenseArmy
  3. Portable Hearing Laboratory

    SBC: BATANDCAT, INC.            Topic: NIDCD

    The National Institute on Deafness and Other Communication Disorders NIDCD has recently funded a number of projects referred further to as concurrent projects to develop portable signal processing tools that provide substantial computing power for real time processing of the acoustic environment The overarching goal is to provide a large group of researchers Community with the means to ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  4. Kinetic Phenotype Discovery Informatics for Neurological Diseases

    SBC: DRVISION TECHNOLOGIES, LLC            Topic: 101

    Project Summary Neurological disorders significantly outnumber diseases in other therapeutic areas and are growing in incidence faster than any other disease classes However the pharmaceutical industry has been unsuccessful in coming up with effective drugs A big factor in these failures has been a lack of adequate model systems for fundamental disease understanding affecting both diagnosis and ...

    SBIR Phase I 2016 Department of Health and Human Services
  5. Attack Major Source of Abused Opioids: Molecularly Deactivate Unused Rx Opioids

    SBC: ELYSIUM THERAPEUTICS, INC.            Topic: NIDA

    Project Summary Abstract Addiction is a disease According to the National Institute on Drug Abuse addiction can be hereditary and can be triggered by environmental conditions and behavior One key environmental factor involves the ready access to unused prescription opioids by potential abusers especially teens Elysium has discovered a novel molecular deactivation XpiRx o ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  6. Commercial Readiness for SAMBA HIV-1 Whole Blood Semi-Quantitative Test for Resource Limited Settings

    SBC: DIAGNOSTICS FOR THE REAL WORLD, LTD            Topic: NIAID

    Diagnostics for the Real World Ltd Commercialization Readiness Pilot Application SAMBA HIV Whole Blood Semi Quantitative Test for Resource Limited Settings Abstract DRW is requesting Technical Assistance and Late Stage Development funding for commercialization of the SAMBA II HIV Semi Q Whole blood test viral load The Project Aims are related to tasks critical for successful commercializ ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  7. Manufacturable and reliable electrically pumped micro-electromechanically tunable vertical cavity surface emitting lasers for low-cost ophthalmic swept source optical coherence tomography

    SBC: PRAEVIUM RESEARCH, INC.            Topic: NEI

    The ultimate goal of this effort is to bring advanced ophthalmic swept source optical coherence tomography SS OCT imaging to low cost broadly accessible environments SS OCT is a powerful non invasive diagnostic imaging modality and an increasingly valuable tool in the early detection and monitoring of a number of retinal diseases as well as in anterior eye and whole eye imaging A key driver ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  8. MR191_ An Immunoprotectant for Marburg Virus

    SBC: MAPP BIOPHARMACEUTICAL, INC.            Topic: NIAID

    PROJECT SUMMARY Mapp Biopharmaceutical Inc Mapp is developing antibody based therapeutics to treat a number of infectious agents including some of the most dangerous known to man the filoviruses Marburg virus is a filovirus endemic to Africa and causes an often lethal hemorrhagic fever Presently there are no approved vaccines or therapeutics to treat Marburg virus infections and this remai ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  9. Noninvasive Contrast Enhanced Early Detection of Melanoma Liver Metastasis

    SBC: INLIGHTA BIOSCIENCES, LLC            Topic: 102

    Abstract The liver is the most common organ for metastasis of various cancers including pancreatic ovarian colorectal gastric cancers and melanoma Uveal melanoma metastasizes in of patients and upon metastasis targets the liver in of these cases The most common primary malignant liver cancer worldwide is hepatocellular carcinoma HCC The use of blind liver biopsy as a diagnostic to ...

    STTR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  10. Delivery of Nanoencapsulated TGFbeta and ATRA for the Treatment of IBD

    SBC: THERAPYX, INC.            Topic: NIAID

    Abstract TGF NanoCap is an oral combination of nanoparticulate transforming growth factor beta TGF and all trans retinoic acid ATRA in pre clinical development for treatment of inflammatory bowel disease IBD Phase I studies provided proof of principle for efficacy in a murine model Phase II work optimized therapeutic protocol confirmed efficacy in a second model established scale up ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health

Agency Micro-sites

US Flag An Official Website of the United States Government